Education
About Us
Working with TipRanks
Follow Us
Rocket Pharmaceuticals (DE:9IP1)
FRANKFURT:9IP1
RESEARCH TOOLSreports
Rocket Pharmaceuticals (9IP1) Ownership Overview
35.12% Insiders
23.53%
Mutual Funds
0.65% Other Institutional Investors
12.99% ETFs
27.71% Public Companies and Individual Investors
The ownership structure of Rocket Pharmaceuticals (DE:9IP1) stock is a mix of institutional, retail, and individual investors. Approximately 37.17% of the company’s stock is owned by Institutional Investors, 35.12% is owned by Insiders, and 27.71% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 22, 2025 | xxxxxxxxxxxxx | $5158 | |
May 22, 2025 | xxxxxxxxxxxxx | $4939 | |
May 22, 2025 | xxxxxxxxxxxxx | $14509 | |
May 22, 2025 | xxxxxxxxxxxxx | $3780 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $74370 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $509714 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $938642 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $4354609 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,157,605 | Insider | 16.85% | 109,435,885 | |
| 16,272,635 | Insider | 15.10% | 98,075,171 | |
| 7,597,585 | Institution | 7.05% | 45,790,645 | |
| 6,519,918 | Institution | 6.05% | 39,295,546 | |
| 5,567,880 | Institution | 5.17% | 33,557,613 | |
| 5,199,218 | Institution | 4.83% | 31,335,687 | |
| 3,865,529 | Institution | 3.59% | 23,297,543 | |
| 2,055,654 | Institution | 1.91% | 12,389,427 | |
| 1,249,039 | Institution | 1.16% | 7,527,958 | |
| 1,198,918 | Insider | 1.11% | 7,225,879 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,597,585 | Institution | 7.05% | 45,790,645 | |
| 5,567,880 | Institution | 5.17% | 33,557,613 | |
| 1,249,039 | Institution | 1.16% | 7,527,958 | |
| 1,007,530 | Institution | 0.94% | 6,072,383 | |
| 994,865 | Institution | 0.92% | 5,996,051 | |
| 856,681 | Institution | 0.80% | 5,163,216 | |
| 788,100 | Institution | 0.73% | 4,749,879 | |
| 770,691 | Institution | 0.72% | 4,644,955 | |
| 697,917 | Institution | 0.65% | 4,206,346 | |
| 683,863 | Institution | 0.63% | 4,121,642 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Rocket Pharmaceuticals (DE:9IP1)?
According to the latest TipRanks data, approximately 0.65% of the company's stock is held by institutional investors, 35.12% is held by insiders, and 27.71% is held by retail investors.
What percentage of Rocket Pharmaceuticals (DE:9IP1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.65% of Rocket Pharmaceuticals (DE:9IP1) stock is held by institutional investors.
What percentage of Rocket Pharmaceuticals (DE:9IP1) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.71% of Rocket Pharmaceuticals (DE:9IP1) stock is held by retail investors.
Who owns the most shares of Rocket Pharmaceuticals (DE:9IP1)?
RTW INVESTMENTS, LP owns the most shares of Rocket Pharmaceuticals (DE:9IP1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.